Pharma

Jeito Capital has reached a major milestone with the final close of Jeito II at €1bn (US$1.2bn), marking the largest fundraise to date for...

Columna Capital has acquired a majority stake in Evidenze Group, a Spain‑based full‑service CRO, from Buenavista Equity Partners. The UK‑based pan‑European lower mid‑market investor...

Jeito Capital, a France-based global independent private equity fund dedicated to Biopharma, has appointed Elaine Caughey as partner, business development and investor relations, and...

Atlas Health, a private equity fund established to invest in European Healthcare companies, has held an oversubscribed final close of its debut fund, Atlas...

Euronext-listed UCB, a Belgium-based global biopharmaceutical company focused on severe neurological and immunological conditions, is to acquire Candid Therapeutics, a US-based privately held clinical-stage biotechnology...

Artificial intelligence is already reshaping workflows and productivity across all industries. The implications for value creation, however, are far from uniform. Filippos Papadopoulos, senior...

Euronext-listed UCB, a Belgium-based global biopharmaceutical company focused on severe neurological and immunological conditions, has acquired the Patients Insights business of IMIDomics, a US-based...

Greenpeak Partners‑backed athagoras, a Germany‑based platform of life sciences consultants, has added Ecker + Ecker and Accessus Health to the group, representing a clear...

Chiesi Group, an Italy-based, family-controlled, international research-focused biopharmaceutical group and certified B Corp, is acquiring Nasdaq-listed KalVista Pharmaceuticals, a global pharmaceutical company focused on...

Astorg, a pan European private equity firm, has signed a definitive agreement to acquire New York-listed Thermo Fisher Scientific’s microbiology business for approximately US$1.075bn,...